Your message has been sent

Thank you, your application has been sent.

What is the subject of your request?

  • General questions
  • Jobs
  • Information for the press

Specify your request

Choose an office

  • Eight Advisory London

  • Eight Advisory Paris

  • Eight Advisory Rennes

  • Eight Advisory Nantes

  • Eight Advisory Lyon

  • Eight Advisory Marseille

  • Eight Advisory Brussels

  • Eight Advisory Frankfurt

  • Eight Advisory Munich

  • Eight Advisory Hamburg

  • Eight Advisory Zürich

  • Eight Advisory Amsterdam

  • Eight Advisory Köln


Unsolicited application

Specify your request


Value Experts – Restructuring & Turnaround

20 Jul 2023


Eight Advisory Brussels


Value Experts – Restructuring & Turnaround

Download report

Since the end of 2021, higher raw material and energy prices along with automatic salary indexation and other inflationary pressures resulted in profitability issues within certain industries. Based on our experience, we see that taking control at an early stage maximises the recovery potential, mitigates cash constraints and can avoid potential restructuring scenarios. Nevertheless, this process becomes more difficult as interest rates rise and lenders increase their risk awareness.

We, at 8advisory, have delivered numerous successful turnarounds thanks to our unique approach which combines both our financial, commercial and operational expertise and involves a high level of seniority. During these turnarounds we closely work together with shareholders and management to assist them in difficult circumstances and identify strategic initiatives.

In this document we would like to introduce you to our hands-on approach and showcase how we can assist you with any of your future endeavours.

To read our whitepaper, click here


de Troyer


Strategy & Operations

Eight Advisory Brussels





Restructuring & Transaction Services

Eight Advisory Brussels


Your message has been sent

Thank you, your application has been sent.

Report request



Eight Advisory supported Ampersand Capital Partners in the context of its acquisition of Julius Clinical Research

29 Nov 2023

Read more

All the news